Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14640511rdf:typepubmed:Citationlld:pubmed
pubmed-article:14640511lifeskim:mentionsumls-concept:C0003392lld:lifeskim
pubmed-article:14640511lifeskim:mentionsumls-concept:C1059478lld:lifeskim
pubmed-article:14640511lifeskim:mentionsumls-concept:C1511636lld:lifeskim
pubmed-article:14640511pubmed:issue11lld:pubmed
pubmed-article:14640511pubmed:dateCreated2003-12-3lld:pubmed
pubmed-article:14640511pubmed:abstractTextTwenty-one compounds, including five new agarofuran sesquiterpenes, reissantins A-E (1-5), were isolated from Reissantia buchananii by means of bioassay-directed fractionation and their structures identified from spectral data. Reissantins A-C are the first reported simple agarofuran sesquiterpenes to contain a 5-carboxy-N-methyl-2-pyridone (CNMP) substituent, which has previously been found only in macroring agarofuran pyridine alkaloids. The major terpenoid components, celastrol (6) and its methyl ester derivative, pristimerin (7), were significantly active against nine cancer cell lines, including A549, MCF-7, HCT-8, KB, KB-VIN, U-87-MG, PC-3, 1A9, and PTX10 cell lines, with ED(50) values ranging from 0.076 to 0.34 microg/mL.lld:pubmed
pubmed-article:14640511pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14640511pubmed:languageenglld:pubmed
pubmed-article:14640511pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14640511pubmed:citationSubsetIMlld:pubmed
pubmed-article:14640511pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14640511pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14640511pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14640511pubmed:statusMEDLINElld:pubmed
pubmed-article:14640511pubmed:monthNovlld:pubmed
pubmed-article:14640511pubmed:issn0163-3864lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:BastowKenneth...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:LeeKuo-Hsiung...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:NakanishiYuka...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:NozakiHiroshi...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:ChangFang-Ron...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:LiawChih-Chua...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:WuYang-ChangY...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:CraggGordon...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:HayashiKen-Ic...lld:pubmed
pubmed-article:14640511pubmed:authorpubmed-author:ChenI-HsiaoIHlld:pubmed
pubmed-article:14640511pubmed:issnTypePrintlld:pubmed
pubmed-article:14640511pubmed:volume66lld:pubmed
pubmed-article:14640511pubmed:ownerNLMlld:pubmed
pubmed-article:14640511pubmed:authorsCompleteYlld:pubmed
pubmed-article:14640511pubmed:pagination1416-20lld:pubmed
pubmed-article:14640511pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:meshHeadingpubmed-meshheading:14640511...lld:pubmed
pubmed-article:14640511pubmed:year2003lld:pubmed
pubmed-article:14640511pubmed:articleTitleAntitumor agents. 228. five new agarofurans, Reissantins A-E, and cytotoxic principles from Reissantia buchananii.lld:pubmed
pubmed-article:14640511pubmed:affiliationGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807, Taiwan, Republic of China.lld:pubmed
pubmed-article:14640511pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14640511pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:14640511lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14640511lld:pubmed